https://strengthpeptide.com Your one-stop resource for strength, recovery, and performance peptides — research, dosing tools, side-effect guides, and plain-English answers. en-us https://strengthpeptide.com/news/peptide-dietary-supplement-fda-2026-05-11 https://strengthpeptide.com/news/peptide-dietary-supplement-fda-2026-05-11 Mon, 11 May 2026 00:00:00 GMT Supplement makers urged FDA to classify peptides including BPC-157 as dietary ingredients, opening a second path to legal U.S. access separate from 503A compounding. https://strengthpeptide.com/news/peptide-sciences-shutdown-market-2026-05-11 https://strengthpeptide.com/news/peptide-sciences-shutdown-market-2026-05-11 Mon, 11 May 2026 00:00:00 GMT PeptideSciences, the largest U.S. research peptide vendor, closed March 6, 2026 as FDA enforcement, quality failures, and new legislation converged. https://strengthpeptide.com/news/sports-medicine-peptide-safety-review-2026-05-11 https://strengthpeptide.com/news/sports-medicine-peptide-safety-review-2026-05-11 Mon, 11 May 2026 00:00:00 GMT A Sports Medicine review of 12 unapproved peptides — including MOTS-c, SS-31, and sermorelin — warns that human safety data are scarce despite promising animal evidence. https://strengthpeptide.com/faq/does-5-amino-1mq-work-fat-loss https://strengthpeptide.com/faq/does-5-amino-1mq-work-fat-loss Mon, 11 May 2026 00:00:00 GMT 5-Amino-1MQ inhibits NNMT, an enzyme highly expressed in fat tissue. Animal data is promising, but human trial data is essentially absent. It's a speculative tool. https://strengthpeptide.com/faq/how-long-does-tb-500-take-to-work https://strengthpeptide.com/faq/how-long-does-tb-500-take-to-work Mon, 11 May 2026 00:00:00 GMT Most users notice reduced pain and better recovery within 2–3 weeks of loading. Deeper tendon and ligament improvements typically emerge at 4–8 weeks. https://strengthpeptide.com/faq/stack-mk-677-with-ipamorelin https://strengthpeptide.com/faq/stack-mk-677-with-ipamorelin Mon, 11 May 2026 00:00:00 GMT Yes — MK-677 and Ipamorelin target GH release through different mechanisms and can be combined, but the case for stacking is weaker than marketing suggests. https://strengthpeptide.com/faq/what-does-ll-37-do https://strengthpeptide.com/faq/what-does-ll-37-do Mon, 11 May 2026 00:00:00 GMT LL-37 is the only human cathelicidin — kills bacteria, breaks down biofilms, and promotes wound healing. A meaningful cancer caution applies. https://strengthpeptide.com/faq/what-is-humanin-peptide https://strengthpeptide.com/faq/what-is-humanin-peptide Mon, 11 May 2026 00:00:00 GMT Humanin is a 21-amino-acid mitochondria-derived peptide with neuroprotective, cardioprotective, and metabolic effects. Levels decline with age. https://strengthpeptide.com/blog/5-amino-1mq-nnmt-fat-loss https://strengthpeptide.com/blog/5-amino-1mq-nnmt-fat-loss Sun, 10 May 2026 00:00:00 GMT 5-Amino-1MQ blocks NNMT to raise NAD+ and drive fat loss in animal models. Here's what the science actually shows and what remains unknown in humans. https://strengthpeptide.com/blog/dsip-sleep-architecture-athletes https://strengthpeptide.com/blog/dsip-sleep-architecture-athletes Sun, 10 May 2026 00:00:00 GMT Delta sleep-inducing peptide explained — mechanism, the limited human evidence, and whether adding DSIP to a recovery protocol is worth it. https://strengthpeptide.com/blog/epitalon-longevity-telomere-evidence https://strengthpeptide.com/blog/epitalon-longevity-telomere-evidence Sun, 10 May 2026 00:00:00 GMT A clear-eyed look at epitalon's telomere research, aging studies, and practical use — including what the data supports and what's still unknown. https://strengthpeptide.com/blog/hgh-fragment-176-191-fat-loss-guide https://strengthpeptide.com/blog/hgh-fragment-176-191-fat-loss-guide Sun, 10 May 2026 00:00:00 GMT HGH fragment 176-191 is GH's lipolytic tail — the clinical trial story, what the animal data showed, and what it means for cutting protocols today. https://strengthpeptide.com/blog/mk-677-vs-ipamorelin-comparison https://strengthpeptide.com/blog/mk-677-vs-ipamorelin-comparison Sun, 10 May 2026 00:00:00 GMT MK-677 and Ipamorelin both raise GH and IGF-1 — but the mechanism, side-effect profile, and practical fit are meaningfully different. Here's how to choose. https://strengthpeptide.com/news/epitalon-telomere-biogerontology-2026-05-10 https://strengthpeptide.com/news/epitalon-telomere-biogerontology-2026-05-10 Sun, 10 May 2026 00:00:00 GMT A Biogerontology study found epitalon lengthens telomeres in human cells via telomerase upregulation — the first Western mechanistic confirmation of Russian work. https://strengthpeptide.com/news/fda-pcac-july-2026-peptides-503a-2026-05-10 https://strengthpeptide.com/news/fda-pcac-july-2026-peptides-503a-2026-05-10 Sun, 10 May 2026 00:00:00 GMT Twelve peptides including BPC-157 and TB-500 were dropped from FDA's Category 2 list. A July 23-24 PCAC meeting will decide whether seven can be compounded legally. https://strengthpeptide.com/news/sports-medicine-journals-peptide-reviews-2026-05-10 https://strengthpeptide.com/news/sports-medicine-journals-peptide-reviews-2026-05-10 Sun, 10 May 2026 00:00:00 GMT AJSM, Sports Medicine, and Sports Health each reviewed injectable peptides in 2025-2026. All three conclude: animal data is strong, human evidence is not. https://strengthpeptide.com/faq/does-mots-c-improve-endurance https://strengthpeptide.com/faq/does-mots-c-improve-endurance Sun, 10 May 2026 00:00:00 GMT Yes — MOTS-c activates AMPK, improves fat burning, and boosted endurance in animal models. Human evidence is early but the mechanism is solid. https://strengthpeptide.com/faq/igf-1-lr3-without-hgh https://strengthpeptide.com/faq/igf-1-lr3-without-hgh Sun, 10 May 2026 00:00:00 GMT Yes, but you lose the natural GH pulse that regulates IGF-1 timing. Standalone IGF-1 LR3 hits harder and longer — which raises the hypoglycemia risk. https://strengthpeptide.com/faq/tesamorelin-visceral-fat https://strengthpeptide.com/faq/tesamorelin-visceral-fat Sun, 10 May 2026 00:00:00 GMT Tesamorelin has the strongest clinical evidence — the only peptide FDA-approved for visceral fat reduction. HGH fragment and AOD-9604 lack equivalent human trial data. https://strengthpeptide.com/faq/what-is-epitalon-aging https://strengthpeptide.com/faq/what-is-epitalon-aging Sun, 10 May 2026 00:00:00 GMT Epitalon is a synthetic pineal peptide studied for telomerase activation and circadian rhythm regulation. Russian research intrigues; replication is sparse. https://strengthpeptide.com/faq/what-is-ss-31-elamipretide https://strengthpeptide.com/faq/what-is-ss-31-elamipretide Sun, 10 May 2026 00:00:00 GMT SS-31 is a mitochondria-targeted peptide that stabilizes cardiolipin and protects cristae structure. Studied for heart failure, kidney injury, and aging. https://strengthpeptide.com/blog/5-amino-1mq-fat-loss-nnmt https://strengthpeptide.com/blog/5-amino-1mq-fat-loss-nnmt Sat, 09 May 2026 00:00:00 GMT 5-Amino-1MQ is an NNMT inhibitor with real fat-loss data in animal models. Here's what it does, where the limits are, and how it's used in practice. https://strengthpeptide.com/blog/dsip-sleep-peptide-guide https://strengthpeptide.com/blog/dsip-sleep-peptide-guide Sat, 09 May 2026 00:00:00 GMT DSIP was the first peptide specifically linked to sleep onset. Here's what the original research showed, where it fell short, and how people use it today. https://strengthpeptide.com/blog/epitalon-telomere-longevity https://strengthpeptide.com/blog/epitalon-telomere-longevity Sat, 09 May 2026 00:00:00 GMT Epitalon is a synthetic tetrapeptide claimed to lengthen telomeres and extend lifespan. Here's what the actual research shows — and what it doesn't. https://strengthpeptide.com/blog/follistatin-344-myostatin-muscle https://strengthpeptide.com/blog/follistatin-344-myostatin-muscle Sat, 09 May 2026 00:00:00 GMT Follistatin 344 blocks myostatin, the brake on muscle growth. Here's what pre-clinical research shows about FST-344 and what you should know before using it. https://strengthpeptide.com/blog/mk-677-water-retention-management https://strengthpeptide.com/blog/mk-677-water-retention-management Sat, 09 May 2026 00:00:00 GMT Water retention is the most common reason people stop MK-677 early. Here's the mechanism, what to expect, and practical strategies to manage it without stopping. https://strengthpeptide.com/news/ajsm-injectable-peptide-primer-2026-05-09 https://strengthpeptide.com/news/ajsm-injectable-peptide-primer-2026-05-09 Sat, 09 May 2026 00:00:00 GMT USC researchers publish an AJSM primer on injectable peptide therapy, covering BPC-157, TB-500, GH secretagogues, and GHK-Cu with formal evidence grades. https://strengthpeptide.com/news/fda-pcac-peptide-503a-review-2026-05-09 https://strengthpeptide.com/news/fda-pcac-peptide-503a-review-2026-05-09 Sat, 09 May 2026 00:00:00 GMT The FDA has scheduled a July 23-24, 2026 PCAC meeting to consider adding BPC-157, TB-500, KPV, MOTS-c, Epitalon, Semax, and Emideltide to the 503A bulks list. https://strengthpeptide.com/news/health-canada-injectable-peptide-warning-2026-05-09 https://strengthpeptide.com/news/health-canada-injectable-peptide-warning-2026-05-09 Sat, 09 May 2026 00:00:00 GMT Health Canada issued a formal public advisory on April 9, 2026, warning against buying or injecting unauthorized peptides online, naming BPC-157 and TB-500. https://strengthpeptide.com/faq/does-epitalon-slow-aging https://strengthpeptide.com/faq/does-epitalon-slow-aging Sat, 09 May 2026 00:00:00 GMT Possibly, in limited pre-clinical and early human data. Epitalon activates telomerase and restores pineal function — but large human trials don't exist yet. https://strengthpeptide.com/faq/does-kpv-help-ibd https://strengthpeptide.com/faq/does-kpv-help-ibd Sat, 09 May 2026 00:00:00 GMT KPV shows consistent anti-inflammatory effects in pre-clinical colitis models and survives oral dosing better than most peptides. No human trials yet. https://strengthpeptide.com/faq/does-tesamorelin-reduce-visceral-fat https://strengthpeptide.com/faq/does-tesamorelin-reduce-visceral-fat Sat, 09 May 2026 00:00:00 GMT Yes — tesamorelin is FDA-approved for visceral fat reduction in HIV lipodystrophy, with ~15–20% reductions in controlled trials. Off-label interest is growing. https://strengthpeptide.com/faq/mix-ipamorelin-cjc-1295-same-syringe https://strengthpeptide.com/faq/mix-ipamorelin-cjc-1295-same-syringe Sat, 09 May 2026 00:00:00 GMT Yes. Ipamorelin and CJC-1295 are stable together in solution and are routinely mixed in a single injection. Here's how to do it correctly. https://strengthpeptide.com/faq/what-does-mots-c-do https://strengthpeptide.com/faq/what-does-mots-c-do Sat, 09 May 2026 00:00:00 GMT MOTS-c is a mitochondrial-derived peptide that activates AMPK, improves insulin sensitivity, and promotes fat oxidation — with early but promising pre-clinical data. https://strengthpeptide.com/blog/ace-031-failed-myostatin-trials-lessons https://strengthpeptide.com/blog/ace-031-failed-myostatin-trials-lessons Fri, 08 May 2026 00:00:00 GMT ACE-031 promised double-muscled physiology. Phase 2 was halted for nosebleeds and capillary bleeding. Here is what really happened and why it matters. https://strengthpeptide.com/blog/aod-9604-clinical-history-peptide-market https://strengthpeptide.com/blog/aod-9604-clinical-history-peptide-market Fri, 08 May 2026 00:00:00 GMT AOD-9604 was supposed to be the clean fat-loss drug. The trials disagreed. Here is what the development history shows and what the peptide market did with it. https://strengthpeptide.com/blog/igf-1-des-vs-lr3-comparison https://strengthpeptide.com/blog/igf-1-des-vs-lr3-comparison Fri, 08 May 2026 00:00:00 GMT IGF-1 DES has higher receptor affinity but a much shorter half-life. LR3 is the longer-acting workhorse. Which one fits which goal — and why most lifters end up on LR3. https://strengthpeptide.com/blog/kpv-peptide-gut-joint-inflammation-lifters https://strengthpeptide.com/blog/kpv-peptide-gut-joint-inflammation-lifters Fri, 08 May 2026 00:00:00 GMT KPV is the C-terminal fragment of alpha-MSH and a potent anti-inflammatory peptide. Where it fits next to BPC-157 and TB-500 for athletes — and where it does not. https://strengthpeptide.com/blog/ll-37-peptide-athletic-recovery https://strengthpeptide.com/blog/ll-37-peptide-athletic-recovery Fri, 08 May 2026 00:00:00 GMT LL-37 is the body's own antimicrobial peptide and a quiet immunomodulator. Here is what it actually does, where it fits for lifters, and where the marketing oversells it. https://strengthpeptide.com/blog/peptides-for-masters-powerlifters-over-50 https://strengthpeptide.com/blog/peptides-for-masters-powerlifters-over-50 Fri, 08 May 2026 00:00:00 GMT Lifters past 50 face declining GH, slower connective-tissue repair, and longer recovery windows. Here is how peptide protocols should actually shift, not just dose lower. https://strengthpeptide.com/blog/ss-31-elamipretide-mitochondrial-recovery https://strengthpeptide.com/blog/ss-31-elamipretide-mitochondrial-recovery Fri, 08 May 2026 00:00:00 GMT SS-31 stabilizes the inner mitochondrial membrane and reduces oxidative stress. The clinical data is strongest in heart failure — here is what that means for athletes. https://strengthpeptide.com/blog/stacking-igf-1-lr3-with-bpc-157 https://strengthpeptide.com/blog/stacking-igf-1-lr3-with-bpc-157 Fri, 08 May 2026 00:00:00 GMT IGF-1 LR3 drives systemic anabolic signaling. BPC-157 drives local healing. The stack is one of the most effective recovery-plus-recomp combinations the community runs. https://strengthpeptide.com/blog/strength-peptides-for-women-dosing-stacks https://strengthpeptide.com/blog/strength-peptides-for-women-dosing-stacks Fri, 08 May 2026 00:00:00 GMT Female lifters running peptides should not just halve the male protocols. Body comp, hormonal context, and side-effect risk all shift the dosing math meaningfully. https://strengthpeptide.com/blog/tapering-vs-cold-stop-peptide-cycle https://strengthpeptide.com/blog/tapering-vs-cold-stop-peptide-cycle Fri, 08 May 2026 00:00:00 GMT Some peptides need a taper. Others can be cold-stopped safely. Here is which is which, why the difference matters, and how to plan the end of a cycle properly. https://strengthpeptide.com/blog/why-hexarelin-desensitizes-faster https://strengthpeptide.com/blog/why-hexarelin-desensitizes-faster Fri, 08 May 2026 00:00:00 GMT Hexarelin produces larger acute GH pulses than ipamorelin or GHRP-6 — and loses them faster. Here is what is happening at the receptor and why protocols look different. https://strengthpeptide.com/news/hytn-bpc-157-spinout-2026-05-08 https://strengthpeptide.com/news/hytn-bpc-157-spinout-2026-05-08 Fri, 08 May 2026 00:00:00 GMT HYTN Innovations is spinning its BPC-157 drug development into a new CSE-listed company aimed at refractory ligament disorders, with a CAD $1M raise. https://strengthpeptide.com/news/precision-peptide-bpc-157-patch-2026-05-08 https://strengthpeptide.com/news/precision-peptide-bpc-157-patch-2026-05-08 Fri, 08 May 2026 00:00:00 GMT Precision Peptide Company says its transdermal BPC-157 patch is near commercial launch as final testing wraps — the first wearable peptide from CSE: BPC. https://strengthpeptide.com/faq/alcohol-on-peptide-cycle https://strengthpeptide.com/faq/alcohol-on-peptide-cycle Fri, 08 May 2026 00:00:00 GMT Moderate alcohol is generally compatible with strength peptide cycles. Heavy drinking blunts GH-pulse benefits and complicates evaluation of effects. https://strengthpeptide.com/faq/are-peptides-legal-us https://strengthpeptide.com/faq/are-peptides-legal-us Fri, 08 May 2026 00:00:00 GMT Most strength peptides are not FDA-approved and sold as research chemicals. Possession is largely unregulated; sale for human use is the legal question. https://strengthpeptide.com/faq/best-place-to-inject-peptides https://strengthpeptide.com/faq/best-place-to-inject-peptides Fri, 08 May 2026 00:00:00 GMT The abdomen is the primary subcutaneous site — about 2 inches lateral to the navel. Outer thigh, upper arm, and upper-outer glute also work.